Delivery Order SPE2DR25D3012-SPE2DR26F4C4S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $23,087.22, with an ultimate completion date of December 3, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The contract utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, valued at $20,868.93. This is a firm fixed price delivery order with no set-aside designation, issued on November 17, 2025, with an ultimate completion date of November 18, 2025. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a competitively competed delivery order valued at $3,771.20 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). The contract, which was awarded on October 30, 2025, with an ultimate completion date of October 31, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,163.78 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets in December 2025, valued at $8,085.56 under a firm fixed-price contract. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026. The product will be delivered to AmerisourceBergen's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a contract ceiling value of $5,094.43. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement through open competition. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $42,302.47 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $10,439.22, with an ultimate completion date of November 25, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,961.42 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $49,790.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Vemlidy 25 mg tablets. This is a non-set-aside award issued on December 4, 2025, with an ultimate completion date of December 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C4SDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,725.36 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (quantity: 30-unit bottles). This competitively awarded, firm fixed price contract is scheduled for completion by November 28, 2025, and represents a non-set-aside procurement. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling and extends through December 2026. This parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA contract portfolio demonstrates extensive experience delivering specialty pharmaceuticals, generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Vemlidy, an antiviral hepatitis B medication, exemplifies AmerisourceBergen's role in providing specialized pharmaceutical commodities to support the Defense Health Agency and other federal healthcare systems through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 11/25/25 |